Literature DB >> 23627013

[Molecular detection assays for 2012 identified novel human coronavirus (HCoV) and probe modification with locked nucleic acid (LNA)].

Wei-Min Zhou1, Rou-Jian Lu, He-Yuan Gong, Hui Li, Xi-Jie Duan, Yang Yang, Wen-Jie Tan.   

Abstract

OBJECTIVE: To develop and optimize the molecular detection assays for recently identified human coronavirus (HCoV) infection.
METHODS: Based on the 208 base pair(bp) sequence of novel HCoV reported by HPA of UK, we designed and obtained several pairs of primer (F-1, R-1; F-2, R-2) and Taqman probes (TZ1,TZ2) for detection of novel HCoV. Two of probes were modified with LNA (LNA-TZ1, LNA-TZ2). Then, RT-PCR and various real time RT-PCR assays were developed and optimized in this study. We also compared our assays with the real time RT-PCR assays reported recently by Europe team based on upE or ORF1b target.
RESULTS: The RT-PCR or real time RT-PCR assays for novel HCoV were developed without cross-reactivity with other HCoV and several common respiratory viruses using clinical specimen panel. The analytical sensitivity of assays were less than 50-500 copies per reaction and the detection was improved when Taqman probe modified with LNA-tagged, compared to no LNA-tagged in real time RT-PCR assays. The upE and LNA-TZ1 based assays were better than others.
CONCLUSION: The molecular detection sensitivity and specificity of TaqMan-based real time PCR assay could be improved when probe tagged with LNA. The upE or LNA-TZ1 based real time RT-PCR assay was recommend for detection of novel HCoV. This study laid a foundation for improving the performance of novel HCoV detection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23627013

Source DB:  PubMed          Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi        ISSN: 1003-9279


  1 in total

Review 1.  A novel human coronavirus: Middle East respiratory syndrome human coronavirus.

Authors:  HeYuan Geng; WenJie Tan
Journal:  Sci China Life Sci       Date:  2013-08-07       Impact factor: 6.038

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.